Safety Study of Navlimetostat Tablet in Healthy Women
This is an early-stage safety study testing a new tablet form of navlimetostat in healthy adult women. The goal is to understand how the body processes this drug and make sure it is safe and well-tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult woman with no significant medical conditions
- Your weight must be in a normal range (BMI between 18.0 and 35.0)
- Your kidney and liver function must be normal or nearly normal based on blood tests
- You must not have had stomach, intestinal, or pancreas problems in the last 3 months
- You must not have uncontrolled nausea, vomiting, or a recent weight-loss surgery
- You must be willing to have physical exams, heart tracings (ECG), and blood tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
This trial studies a new experimental drug, called navlimetostat, in healthy women to understand how the body processes and gets rid of it. It is an important early step before the drug can be tested in patients with cancer.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This trial tests a new drug, Navlimetostat (BMS-986504), for people with advanced solid tumors that have a specific genetic change called MTAP deletion or loss. It looks at safety, side effects, and how the drug works in the body.
This early-phase study tests a new oral tablet (YR011) in healthy volunteers to see how safe it is and how the body processes it. It helps find the right dose for future studies.
This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.